Association of a common allelic polymorphism (C677T) in the methylene tetrahydrofolate reductase gene with a reduced risk of osteoporotic fractures. A case control study in Danish postmenopausal women

Calcified Tissue International

Volumn 71, Issue 5, 2002, Pages 386-392

  Jorgensen H L ^a   Madsen, J S ^b   Madsen, B ^a   Saleh, M M A ^a   Abrahamsen, B ^c   Fenger, M ^a   Lauritzen, J B ^a  

^a HVIDOVRE HOSPITAL   (Denmark)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

^c AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

BMD; MTHFR (C677T); Mutation; Osteoporosis; Ultrasound

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2);

AGED; ALLELE; ARTICLE; BONE DENSITY; BONE MINERAL; CALCANEUS; CASE CONTROL STUDY; CONTROLLED STUDY; DENMARK; DISEASE ASSOCIATION; DUAL ENERGY X RAY ABSORPTIOMETRY; ECHOGRAPHY; FEMALE; FOREARM FRACTURE; FRAGILITY FRACTURE; GENETIC POLYMORPHISM; GENOTYPE; HEEL; HIP FRACTURE; HOMOZYGOSITY; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; POINT MUTATION; POLYMERASE CHAIN REACTION; POSTMENOPAUSE; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; STATISTICAL SIGNIFICANCE; WILD TYPE;

AGED; ALLELES; BONE DENSITY; CALCANEUS; CASE-CONTROL STUDIES; DENMARK; DNA; DNA MUTATIONAL ANALYSIS; FEMALE; FOREARM INJURIES; GENETIC PREDISPOSITION TO DISEASE; HIP FRACTURES; HUMANS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; MUTATION; ODDS RATIO; OSTEOPOROSIS, POSTMENOPAUSAL; OXIDOREDUCTASES ACTING ON CH-NH GROUP DONORS; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 0038099459     PISSN: 0171967X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00223-001-2126-3     Document Type: Article

References (36)

1. Levin RM (1991) The prevention of osteoporosis. Hosp Pract 26:77-94
2. NIH Consensus Development Panel (2001) Osteoporosis prevention, diagnosis, and therapy. JAMA 285:785-795
3. Pocock NA, Eisman JA, Hopper JL, Yeates MG, Sambrook PN, Ebert S (1987) Genetic determinants of bone mass in adults, a twin study. J Clin Invest 80:706-710
4. Seeman E, Hopper JL, Bach LA, Cooper ME, Parkinson E, Mckay J, Jerums G (1989) Reduced bone mass in daughters of women with osteoporosis. N EngI J Med 320:554-558
5. Gueguen R, Jouanny P, Guillemin F, Kuntz C, Pourel J, Siest G (1995) Segregation analysis and variance components analysis of bone mineral density in healthy families. J Bone Miner Res 10:2017-2022
6. Eisman JA (1999) Genetics of osteoporosis. Endocr Rev 20:788-804
7. Hobson EE, Ralston SH (2001) Role of genetic factors in the pathophysiology and management of osteoporosis. Clin Endocrinol (Oxf) 54:1-9
8. Geisel J, Zimbelmann I, Schorr H, Knapp JP, Bodis M, Hubner U, Herrmann W (2001) Genetic defects as important factors for moderate hyperhomocysteinemia. Clin Chem Lab Med 39:698-704
9. Passaro A, Vanini A, Calzoni F, Alberti L, Zamboni PF, Fellin R, Solini A (2001) Plasma homocysteine, methylenetetrahydrofolate reductase mutation and carotid damage in elderly healthy women. Atherosclerosis 157: 175-180
10. Dekou V, Whincup P, Papacosta O, Ebrahim S, Lennon L, Ueland PM, Refsum H, Humphries SE, Gudnason V (2001) The effect of the C677T and A1298C polymorphisms in the methylenetetrahydrofolate reductase gene on homocysteine levels in elderly men and women from the British regional heart study. Atherosclerosis 154:659-666
11. Yap S, Naughten ER, Wilcken B, Wilcken DE, Boers GH (2000) Vascular complications of severe hyperhomocysteinemia in patients with homocystinuria due to cystathionine beta-synthase deficiency: effects of homocysteine-lowering therapy. Semin Thromb Hemost 26:335-340
12. Lubec B, Fang-Kircher S, Lubec T, Blom HJ, Boers GH (1996) Evidence for McKusick's hypothesis of deficient collagen cross-linking in patients with homocystinuria. Biochim Biophys Acta 1315:159-162
13. Parrot F, Redonnet-Vernhet I, Lacombe D, Gin H (2000) Osteoporosis in late-diagnosed adult homocystinuric patients. J Inherit Metab Dis 23:338-340
14. Hak AE, Polderman KH, Westcndorp IC, Jakobs C, Hofman A, Witteman JC, Stehouwer CD (2000) Increased plasma homocysteine after menopause. Atherosclerosis 149:163-168
15. Miyao M, Morita H, Hosoi T, Kurihara H, Inoue S, Hoshino S, Shiraki M, Yazaki Y, Ouchi Y (2000) Association of methylenetetrahydrofolate reductase (MTHFR) polymorphism with bone mineral density in postmenopausal Japanese women. Calcif Tissue Int 66:190-194
16. Salch MMA, Jørgensen HL, Lauritzen JB (2002) Odds ratios for hip and lower forearm fracture using peripheral bone densitometry - a case control study postmenopausal women. Clin Physiol Func Im 22:58-63
17. Jørgensen HL, Hassager C (1997) Improved reproducibility of broadband ultrasound attenuation of the os calcis by using a specific region of interest. Bone 21:109-112
18. Altman DG (1991) Practical statistics for medical research. Chapman & Hall, London
19. Falconer DS, Mackay TFC (1996) Introduction to quantitative genetics, 4th ed. Addison Wesley Longman Limited, Essex, England
20. SAS/STAT User's guide (1994) Version 6, 4th ed. SAS Institute Inc., Cary, NC, USA
21. Garnero P, Sornay-Rendu E, Claustrat B, Delmas PD (2000) Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: the OFELY study. J Bone Miner Res 15:1526-1536
22. Mann V, Hobson EE, Li B, Stewart TL, Grant SF, Robins SP, Aspden RM, Ralston SH (2001) A COL1A1 Sp1 binding site polymorphism predisposes to osteoporotic fracture by affecting bone density and quality. J Clin Invest 107:899-907
23. Ross PD, Norimatsu H, Davis JW, Yano K, Wasnich RD, Fujiwara S, Hosoda Y, Melton LJ 3rd (1991) A comparison of hip fracture incidence among native Japanese, Japanese Americans, and American Caucasians. Am J Epidemiot 133:801-809
24. Orimo H, Hashimoto T, Sakata K, Yoshimura N, Suzuki T, Hosoi T (2000) Trends in the incidence of hip fracture in Japan, 1987-1997: the third nationwide survey. J Bone Miner Metab 18:126-131
25. Refsum H, Ueland PM, Nygard O, Vollset SE (1998) Homocysteine and cardiovascular disease. Annu Rev Med 49:31-62
26. Krumdieck CL, Prince CW (2000) Mechanisms of homocysteine toxicity on connective tissues: implications for the morbidity of aging. J Nutr 130 (2S suppl):365S-368S
27. Kauwell GP, Wilsky CE, Cerda JJ, Herrlinger-Garcia K, Hutson AD, Theriaque DW, Boddie A, Rampersaud GC, Bailey LB (2000) Methylenetetrahydrofolate reductase mutation (677C-> T) negatively influences plasma homocysteine response to marginal folate intake in elderly women. Metabolism 49:1440-1443
28. Rasmussen LB, Ovesen L, Bulow I, Knudsen N, Laurberg P, Perrild H (2000) Folate intake, lifestyle factors, and homocysteine concentrations in younger and older women. Am J Clin Nutr 72:1156-1163
29. Hiraoka M (2001) Nutritional status of vitamins A, E, C, B1, B2, B6, nicotinic acid, B12, folate, and beta-carotene in young women. J Nutr Sci Vitaminol (Tokyo) 47:20-27
30. Payne DA, Chamoun AJ, Seifert SL, Stouffer GA (2001) Mthfr 677 c->t mutation: a predictor of early-onset coronary artery disease risk. Thromb Res 103:275-279
31. Kawamoto R, Kohara K, Tabara Y, Miki T, Doi T, Tokunaga H, Konishi I (2001) An association of 5,10-methylenetetrahydrofolate reductase (MTHFR) gene polymorphism and common carotid atherosclerosis. J Hum Genet 46:506-510
32. Topic E, Timundic AM, Ttefanovic M, Demarin V, Vukovic V, Lovrencic-Huzjan A, Zuntar I (2001) Polymorphism of apoprotein E (APOE), methylenetetrahydrofolate reductase (MTHFR) and paraoxonase (PONI) genes in patients with cerebrovascular disease. Clin Chem Lab Med 39:346-350
33. Roest M, van der Schouw YT, Grobbee DE, Tempelman MJ, de Groot PG, Sixma JJ, Banga JD (2001) Methylenetetrahydrofolate reductase 677 C/T genotype and cardiovascular disease mortality in postmenopausal women. Am J Epidemiol 153:673-679
34. Houlston RS, Tomlinson IP (2001) Polymorphisms and colorectal tumor risk. Gastroenterology 121: 282-301
35. Wiemels JL, Smith RN, Taylor GM, Eden OB, Alexander FE, Greaves MF (2001) Methylenetetrahydrofolate reductase (MTHFR) polymorphisms and risk of molecularly defined subtypes of childhood acute leukemia. Proc Natl Acad Sci USA 98:4004-4009
36. Yeowell HN, Walker LC (2000) Mutations in the lysyl hydroxylase 1 gene that result in enzyme deficiency and the clinical phenotype of Ehlers-Danlos syndrome type VI. Mol Genet Metab 71:212-224